Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Current Assets (2021 - 2026)

Prokidney's (PROK) quarterly Current Assets came in at $189.8 million in Q2 2026, down 41.51% year-over-year from $324.4 million in Q2 2025, and down 19.21% quarter-over-quarter from $234.9 million in Q1 2026.

Analysis

Prokidney (PROK) Current Assets (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Current Assets for 6 consecutive years, with $189.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Assets fell 41.51% year-over-year to $189.8 million in Q2 2026; TTM through Jun 2026 was $189.8 million, a 41.51% decrease from a year earlier, with the FY2025 full-year figure at $280.7 million, down 29.1% from the prior year.
  • Current Assets was $189.8 million for Q2 2026 at Prokidney, down from $234.9 million in the prior quarter.
  • Over five years, Current Assets peaked at $519.4 million in Q3 2022 and troughed at $594977.0 in Q1 2022.
  • A 5-year average of $336.6 million and a median of $366.9 million in 2023 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets jumped 80599.42% in 2023 and sank 41.51% in 2026, its largest moves.
  • Over 5 years, Current Assets stood at $504.7 million in 2022, then retreated by 25.87% to $374.1 million in 2023, then climbed by 5.81% to $395.9 million in 2024, then dropped by 29.1% to $280.7 million in 2025, then plunged by 32.39% to $189.8 million in 2026.
  • The last three Current Assets figures came in at $189.8 million (Q2 2026), $234.9 million (Q1 2026), and $280.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.06 Bn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 2.37 Bn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 464.26 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 1.23 Bn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 834.27 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 1.18 Bn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 134.38 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 2.22 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 264.73 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 189.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 189.77 Mn
Mar 31, 2026 234.90 Mn
Dec 31, 2025 280.68 Mn
Sep 30, 2025 299.99 Mn
Jun 30, 2025 324.44 Mn
Mar 31, 2025 359.66 Mn
Dec 31, 2024 395.88 Mn
Sep 30, 2024 430.23 Mn
Jun 30, 2024 450.26 Mn
Mar 31, 2024 340.16 Mn
Dec 31, 2023 374.15 Mn
Sep 30, 2023 406.42 Mn
Jun 30, 2023 466.43 Mn
Mar 31, 2023 480.14 Mn
Dec 31, 2022 504.72 Mn
Sep 30, 2022 519.37 Mn
Jun 30, 2022 632,296.00
Mar 31, 2022 594,977.00
Dec 31, 2021 27.27 Mn
Sep 30, 2021 1.44 Mn